Wegovy vs Zepbound: which one should I ask for and where do I get either online?

Short answer

• Both are prescription weekly injectable drugs for weight loss. Zepbound (tirzepatide, Eli Lilly) generally produces larger average weight loss in trials than Wegovy (semaglutide, Novo Nordisk), but both cause similar GI side effects and have important safety considerations. Which one you “should ask for” depends on your medical history, other medicines, pregnancy plans, and how much weight loss you and your clinician want to aim for. Talk with your primary care doctor or an obesity specialist to decide.

How they differ (brief)

• Mechanism: Wegovy = semaglutide (GLP‑1 receptor agonist). Zepbound = tirzepatide (GIP + GLP‑1 dual agonist).
• Efficacy: Clinical trials show tirzepatide tends to produce greater average percent weight loss than semaglutide, especially at higher doses. Individual response varies.
• Side effects: Both commonly cause nausea, vomiting, diarrhea, constipation and can cause gallbladder issues and pancreatitis in rare cases. Dose escalation is used to improve tolerability.
• Safety warnings: Both have boxed/label warnings about thyroid C‑cell tumors in rodents and are generally not recommended in pregnancy. They can interact with diabetes medicines (risk of hypoglycemia) and aren’t appropriate with certain histories (eg, personal/family medullary thyroid cancer/MEN2).
• Dosing: Both are weekly injections but titration schedules differ.

Which to ask for

• If you want the largest average weight loss and have no contraindications, Zepbound (tirzepatide) is often favored by clinicians.
• If you or your doctor prefer the longer clinical experience and extensive obesity-specific data, Wegovy (semaglutide) is a reasonable choice.
• If you have type 2 diabetes, insulin/sulfonylurea use, or other complex medical issues, your provider may pick one drug or the other based on glucose control and safety.
  Bottom line: don’t self-prescribe — discuss the tradeoffs with your clinician and let them tailor the choice and monitoring to you.

Where to get them online

1. Get a prescription first
   • You must have a prescription from a licensed clinician (PCP, endocrinologist, obesity medicine specialist). Many clinicians can evaluate by telehealth.
2. Telehealth clinics that commonly evaluate and prescribe GLP‑1 or tirzepatide (examples)
   • Ro (Roman) — offers medical weight‑loss programs and prescriptions after an online visit.
   • Hims & Hers — provides telehealth weight‑loss visits and can prescribe GLP‑1s where appropriate.
   • PlushCare — primary care + telehealth; clinicians can prescribe and coordinate follow‑up.
   • Calibrate and Form Health — programs focused on metabolic/weight management (availability varies by state).
   • NOTE: availability, formularies, and whether they prescribe a specific brand (Zepbound vs Mounjaro vs Wegovy vs Ozempic) vary by company and by state.
3. Fill the prescription at reputable pharmacies
   • National chains and online pharmacies that will dispense with a valid prescription: CVS, Walgreens, Walmart, Kroger, Amazon Pharmacy, and major mail‑order/insurance pharmacies.
4. Manufacturer resources and savings
   • Wegovy: Novo Nordisk has a patient support site and savings/copay program for eligible commercially insured patients. Visit the Wegovy website or ask your prescriber to enroll you.
   • Zepbound: Eli Lilly offers patient assistance and savings programs; check Zepbound.com or Lilly’s patient support for details.
5. Cost & insurance
   • These drugs can be expensive without coverage (hundreds to thousands of dollars per month). Check with your insurer/benefit manager and the manufacturer savings programs. Prior authorization is often required.
6. Avoid risky sources
   • Don’t buy these drugs from overseas online pharmacies, social media sellers, or without a prescription — counterfeit or mishandled products are common and unsafe.

If you want, I can:

• Help you draft questions to take to your clinician, or
• Look up telehealth providers that operate in your state and their current offerings (tell me your state), or
• Give a short list of specific questions to ask about safety, monitoring, and costs. Which would you like?